Donoghue Forlines’s Denali Therapeutics DNLI Stock Holding History

Donoghue Forlines’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,341	Closed	-$1.54M	–	240
2020 Q4	$1.54M	Buy	+18,341	New	+$1.11M	0.3%	73

Other funds holding DNLI

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Donoghue Forlines's DNLI Position: Q1 2021 in Review

Donoghue Forlines sold out of Denali Therapeutics (DNLI) in Q1 2021, closing a stake of 18,341 shares — an estimated $1.54M sold.

Donoghue Forlines first reported a position in DNLI in Q4 2020 and held it in 1 quarter. The position peaked at $1.54M in Q4 2020. 216 funds tracked by Wall St. Rank hold DNLI as of Q1 2021.

Donoghue Forlines reported no remaining Denali Therapeutics position as of Q1 2021 after selling out during the quarter.
Donoghue Forlines sold 18,341 Denali Therapeutics shares in Q1 2021, an estimated $1.54M.
Donoghue Forlines first reported a position in Denali Therapeutics in Q4 2020 and held it in 1 quarter.
Donoghue Forlines's Denali Therapeutics position peaked at $1.54M in Q4 2020.
216 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2021.

Based on Donoghue Forlines's 13F filing for Q1 2021, filed 14 May 2021.